Endemic pemphigus vulgaris

Archives of Dermatology

Volumn 143, Issue 7, 2007, Pages 895-899

  Rocha Alvarez, Rosicler ^a   Ortega Loayza, Alex G ^c   Friedman, Horacio ^a   Campbell, Iphis ^a   Aoki, Valeria ^b   Rivitti, Evandro A ^b   Dasher, David ^c   Li, Ning ^c   Diaz, Luis A ^c  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 3;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPRECIPITATION; MALE; PATIENT ASSESSMENT; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AUTOANTIBODIES; BRAZIL; CASE-CONTROL STUDIES; DESMOGLEIN 1; DESMOGLEIN 3; ENDEMIC DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; SEROEPIDEMIOLOGIC STUDIES;

EID: 34447560088     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.7.895     Document Type: Article

References (40)

1. Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest. 1994;94(1):59-67.
2. Ding X, Aoki V, Mascaro JM Jr, Lopez-Swiderski A, Diaz LA, Fairley JA. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol. 1997;109(4):592-596.
3. Ding X, Diaz LA, Fairley JA, Giudice GJ, Liu Z. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol. 1999; 112(5):739-743.
4. Brenner S, Dorfman B, Himelfrab M. Familial pemphigus vulgaris. Dermatologica. 1985;171(1):38-40.
5. Laskaris G, Sklavounou A, Stavrou A, Stavropoulou K. Familial pemphigus vulgaris with oral manifestation affecting two Greek families. J Oral Pathol Med. 1989; 18(1):49-53.
6. Katzenelson V, David M, Zamir R, Mellibovsky J, Idises C, Sandbank M. Familial pemphigus vulgaris. Dermatologica. 1990;181(1):48-50.
7. Starzycki Z, Chorzelski TP, Jablonska S. Familial pemphigus vulgaris in mother and daughter. Int J Dermatol. 1998;37(3):211-214.
8. Gokdemir G, Gonen S, Kwanc-Altunay I, Koslu A. Familial pemphigus vulgaris: two siblings with unusual localized variant. Int J Dermatol. 2006;45(2): 170-172.
9. Ahmed AR, Mohimen A, Yunis EJ, et al. Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients. J Exp Med. 1993;177(2):419-424.
10. Roscoe JT, Diaz L, Sampaio SA, et al. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol. 1985;85(6):538-541.
11. Rock B, Labib RS, Diaz LA. Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest. 1990;85(1):296-299.
12. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Antigenic-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol. 1994;104(6):895-901.
13. Diaz LA, Sampaio SA, Rivitti EA, et al. Endemic pemphigus foliaceus (fogo selvagem), I: clinical features and immunopathology. J Am Acad Dermatol. 1989; 20(4):657-669.
14. Diaz LA, Sampaio SAP, Rivitti EA, et al. Endemic pemphigus foliaceus (fogo selvagem), II: current and historic epidemiologic studies. J Invest Dermatol. 1989; 92(1):4-12.
15. Hans-Filho G, dos Santos V, Katayama JH, et al. An active focus of high prevalence of fogo selvagem on an Amerindian reservation in Brazil. J Invest Dermatol. 1996;107(1):68-75.
16. Warren SJ, Lin MS, Giudice GJ, et al; Cooperative Group on Fogo Selvagem Research. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. N Engl J Med. 2000;343(1):23-30.
17. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med. 2003;197(11):1501-1510.
18. Diaz LA, Arteaga LA, Hilario-Vargas J, et al; Cooperative Group on Fogo Selvagem Research. Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to fogo selvagem. J Invest Dermatol. 2004;123(6):1045-1051.
19. Robledo MA, Prada S, Jaramillo D, Leon W. South American pemphigus foliaceus: study of an epidemic in El Bagre and Nechi, Colombia 1982 to 1986. Br J Dermatol. 1988;118(6):737-744.
20. Abrèu-Velez AM, Hashimoto T, Bollag WB, et al. A unique form of endemic pemphigus in northern Colombia. J Am Acad Dermatol. 2003;49(4):599-608.
21. Ortega Loayza AG, Ramos W, Elgart GW, et al. Antibodies against desmoglein 1 in healthy subjects in endemic and nonendemic areas of pemphigus foliaceus (fogo selvagem) in Peru. Int J Dermatol. 2006;45(5):538-542.
22. Kallel Sellami M, Ben Ayed M, Mouquet H, et al. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrences of Tunisian pemphigus foliaceus. Clin Exp Immunol. 2004;137 (1):195-200.
23. Iwatsuki K, Takigawa M, Hashimoto T, Nishikawa T, Yamada M. Can pemphigus vulgaris become pemphigus foliaceus? J Am Acad Dermatol. 1991;25(5 pt 1): 797-800.
24. Kawana S, Hashimoto T, Nishikawa T, Nishiyama S. Shift in clinical features, histologic findings and antigen profiles from pemphigus vulgaris to pemphigus foliaceus: two case studies. Dermatology. 1994;189(suppl 1):57-59.
25. Chang SN, Kim SC, Lee IJ, Seo SJ, Hong CK, Park WH. Transition from pemphigus vulgaris to pemphigus foliaceus. Br J Dermatol. 1997;137(2):303-305.
26. Komai A, Amagai M, Ishii K, et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Br J Dermatol. 2001;144(6):1177-1182.
27. Harman KE, Gratian MJ, Shirlaw PJ, et al. The transition of PV into PF: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Br J Dermatol. 2002;146(4):684-687.
28. Hashimoto T, Konohana A, Nishikawa T. Immunoblot assay as an aid to the diagnoses of unclassified cases of pemphigus. Arch Dermatol. 1991;127(6): 843-847.
29. Ishii K, Amagai M, Ohata Y, et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol. 2000;42(5 pt 2): 859-861.
30. Arteaga LA, Prisayanh PS, Warren SJP, et al. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against desmoglein-1 and desmoglein-3. J Invest Dermatol. 2002;118(5):806-811.
31. Hilario-Vargas J, Dasher DA, Li N, et al; Cooperative Group on Fogo Selvagem Research. Prevalence of anti-desmoglein-3 antibodies in endemic regions of fogo selvagem in Brazil. J Invest Dermatol. 2006;126(9):2044-2048.
32. Rocha-Alvarez R, Campbell IP, Friedman H, Aoki V, Diaz LA. Aspectos nao usuais de penfigo vulgar em areas endemicas de penfigo foliaceo endemico [Non-usual aspects of pemphigus vulgaris in endemic areas of endemic pemphigus foliaceus.][abstract]. In: Program and abstracts of the 50th Congreso da Sociedade Brasileira de Dermatologia; September 1995; Belém, Para, Brazil.
33. Ribeiro AM, Alvarez RR, Friedman H, Campbell I; Cooperative Group on Fogo Selvagem Research. The profile of fogo selvagem (endemic pemphigus foliaceus) at the University Hospital of Brasilia-Brazil: epidemiological and clinical considerations. Int J Dermatol. 2005;44(4):293-298.
34. Auad A. Penfigo foliaceo Sul-Americano no estado de Goiás, Brazil [South American pemphigus foliaceus in the state of Goiás, Brazil]. Rev Patol Trop. 1972; 1:293-346.
35. Chaves Silvestre M, de Almeida Netto JC. Endemic pemphigus foliaceus: social and demographical characteristics and incidence in the microregions of Goiás, based on patients seen at the Tropical Diseases Hospital, Goiânia-Goiás. An Bras Dermatol. 2005;80(3):261-266.
36. Amagai M, Komai A, Hashimoto T, et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol. 1999;140(2):351-357.
37. Matis WL, Anhalt GJ, Diaz LA, Rivitti EA, Martins CR, Berger RS. Calcium enhances the sensitivity of immunofluorescence for pemphigus antibodies. J Invest Dermatol. 1987;89(3):302-304.
38. Empinotti JC, Diaz LA, Martins CR, et al; Cooperative Group for Fogo Selvagem Research. Endemic pemphigus foliaceus in western Parana (1976-1988). Br J Dermatol. 1990;123(4):431-437.
39. Gomez Lotze E. O Penfigo em Mato Grosso do Sul. São Paulo, Brazil: Tese em V Curso Descentralizado de Saude Publica/MS; 1988.
40. Mansur J de S, Mansur MC de A, Azulay RD. O penfigo foliaceo sul Americano em um hospital universitario do Rio de Janeiro [South American pemphigus foliaceus in Rio de Janeiro University Hospital]. An Bras Dermatol Sifilol. 1975; 50:283-296.